Abstract
The objective of this review is to report the Clinical Year in Review proceedings in the field of nonsmall cell lung cancer that were presented at the 2012 European Respiratory Society Congress in Vienna, Austria. Various topics were reviewed, including epidemiology, screening, diagnosis, treatment, prognosis, and palliative and end of life care.
MeSH terms
-
Biomarkers, Tumor / metabolism
-
Carcinoma, Non-Small-Cell Lung / diagnosis
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / epidemiology
-
Carcinoma, Non-Small-Cell Lung / metabolism
-
Chemotherapy, Adjuvant
-
Early Detection of Cancer
-
Humans
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / epidemiology
-
Lung Neoplasms / metabolism
-
Molecular Targeted Therapy*
-
Palliative Care
-
Pneumonectomy
-
Predictive Value of Tests
-
Signal Transduction / drug effects*
-
Treatment Outcome